换一批
换一批A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
作者：
Sun Kyung,Baek [1]
;
Jae-Ho,Jeong [2]
;
KyungHae,Jung [2]
;
Hee Kyung,Ahn [3]
;
Min Hwan,Kim [4]
;
Joohyuk,Sohn [4]
;
In Hae,Park [5]
;
Jin Seok,Ahn [6]
;
Dae-Won,Lee [7]
;
Seock-Ah,Im [7]
;
Sung Hoon,Sim [8]
;
Keun Seok,Lee [8]
;
Jee,Hyun Kim [9]
;
Hyun-Jeong,Shim [10]
;
Yeesoo,Chae [11]
;
Su-Jin,Koh [12]
;
Hyorak,Lee [13]
;
Jieun,Lee [14]
;
Jae-Ho,Byun [15]
;
Youngmi,Seol [16]
;
Eun Mi,Lee [17]
;
Hee-Jung,Jee [18]
;
Hyonggin,An [18]
;
Eun Byeol,Park [18]
;
Young Ju,Suh [19]
;
Kyoung Eun,Lee [20]
;
Yeon Hee,Park [21]
;
Korean Cancer Study Group (KCSG)
作者单位：
Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea.
[1]
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
[2]
Division of Medical Oncology and Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
[3]
Division of Medical Oncology and Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
[4]
Division of Oncology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
[5]
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
[6]
Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
[7]
Center for Breast Cancer, National Cancer Center, Goyang, Republic of Korea.
[8]
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
[9]
Department of Hematology-Oncology, Chonnam National University Medical School and Hwasun Hospital, Gwangju, Republic of Korea.
[10]
Department of Internal Medicine, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
[11]
Department of Hematology and Oncology, Ulsan University Hospital, Ulsan, Republic of Korea.
[12]
Division of Hematology/Oncology, Korea Cancer Center Hospital, Seoul, Republic of Korea.
[13]
Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
[14]
Division of Medical Oncology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.
[15]
Division of Hematology and Oncology, Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
[16]
Department of Internal Medicine, Kosin University Gaspel Hospital, Busan, Republic of Korea.
[17]
Department of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.
[18]
Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Republic of Korea.
[19]
Department of Hematology and Oncology, Ewha Womans University Hospital, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Republic of Korea.
[20]
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.
[21]
DOI
10.1177/17588359231225029
PMID
38288157
发布时间
2024-10-23
- 浏览0
Therapeutic advances in medical oncology
17588359231225029页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
